Sleep Apnea and Your Kidneys
Observational studies suggested CPAP slows kidney function decline. When the randomised trials were pooled separately, the effect disappeared. That gap between study designs is the most useful thing in this literature.
Obstructive sleep apnea is associated with an increased risk of chronic kidney disease, and sleep apnea is highly prevalent among people who already have kidney disease. The relationship appears to run in both directions, which is unsurprising — the two share hypertension, obesity and fluid distribution as common ground.
The interesting question is whether treating the apnea protects the kidneys. The answer is a good lesson in reading evidence.
What the pooled analysis found
A 2025 systematic review and meta-analysis gathered four randomised controlled trials and seven non-randomised studies, 2,660 people in total, measuring two standard markers of kidney function: estimated glomerular filtration rate (eGFR) and the urinary albumin-to-creatinine ratio (UACR).
Here is the result, and the split is the point:
| Study type | Effect of CPAP on eGFR decline |
|---|---|
| Non-randomised studies | Significant benefit (MD 1.95, 95% CI 0.80 to 3.11, p<0.001) |
| Randomised controlled trials | Not significant (MD 1.42, 95% CI −0.99 to 3.82, p=0.25) |
And on albumin in the urine, there was no significant association at all (MD −0.05, 95% CI −0.41 to 0.30, p=0.77).
The authors' conclusion: with low to moderate certainty of evidence, CPAP therapy has little to no effect on alleviating the decline in renal function, and larger randomised trials with longer follow-up are needed.
Why that split matters more than either number
When observational studies show a benefit and randomised trials of the same question do not, the usual explanation is not that one set is wrong. It is confounding by adherence.
People who use CPAP consistently differ from people who do not, in ways that affect kidney function independently: they tend to be more engaged with their health generally, take other medications more reliably, attend appointments, and have better-controlled blood pressure. An observational study comparing users with non-users is partly comparing conscientiousness, and conscientiousness protects kidneys.
Randomisation breaks that link, and when it does here, the effect shrinks to nothing distinguishable from zero.
Note also the direction of the numbers: the point estimates are similar (1.95 versus 1.42). What changed is the confidence interval, which in the randomised data crosses zero. This is not a reversal so much as a loss of certainty — which is exactly what honest evidence looks like when the supporting design is removed.
Evidence tier 1 that apnea and kidney disease are associated. Tier 3 that CPAP preserves kidney function — pooled randomised data does not support it.
What this does and does not mean
It is not a reason to skip CPAP. This is the important part. The cardiovascular, metabolic, sleepiness and accident-risk cases for treating moderate-to-severe apnea stand on their own evidence and are not affected by this. What untreated apnea accumulates.
It is a reason to be sceptical of renal protection as a selling point. If you have been told CPAP will protect your kidneys, that specific claim is not supported by the randomised evidence.
The association still matters diagnostically. Because apnea is highly prevalent in chronic kidney disease, and because fluid shifts overnight in kidney disease can worsen airway collapse, someone with CKD who snores and is sleepy has a good reason to be assessed. Newer work is examining whether apnea shows up in early renal injury biomarkers before conventional measures move.
Blood pressure is the lever that acts on both. Hypertension damages kidneys and is both a cause and a consequence of apnea, and it is where the shared benefit most plausibly sits. Snoring and blood pressure.
This is the same pattern as the cardiovascular question, where large randomised trials tempered what observational data had promised — worth reading alongside. Does CPAP reduce cardiovascular risk?
And if you have not been tested: witnessed breathing pauses, gasping arousals, waking unrefreshed, or sleepiness that more sleep does not fix are what warrant a sleep study. Snoring versus apnea.